Key Points Non-GAAP EPS far surpassed analyst expectations, reaching $0.63 compared to an estimated loss of $0.18 for Q2 2025. GAAP revenue reached $234.5 million, outperforming the $188.69 million ...

Key Points MetLife's adjusted earnings per share (Non-GAAP) fell to $2.02, missed estimates by 6.0% (non-GAAP) and declining 11% from the prior year (non-GAAP, Q2 2025 vs. Q2 2024). Revenue (GAAP) was ...

For Q3 2025, Sprout Social expects revenue in the range of $114.4 million to $115.2 million and non-GAAP net income per share of between $0.15 and $0.16. For the full year 2025, the company now ...

While the company exceeded analyst expectations on several fronts, its Q3 outlook includes softer revenue and a slide back ...

MongoDB's growth is seen slowing down sharply, with 2026 guidance pointing to low-double digit revenue expansion. Read what ...

Separately, the company raised its 2025 target for its Texas Residential Virtual Power Plant (VPP) program from 20 MW to 150 ...

Full-year 2025 guidance raised: New revenue outlook is $790 million to $850 million for full year 2025, up $110 million at ...

Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced today ...

Please note that the limited information that follows in this press release is not adequate to make an informed investment judgment.

Q3 2025 Management View CEO Nicholas Lahanas highlighted "a solid third quarter, driven by strong cross-functional collaboration, disciplined execution and the unwavering dedication of team Central ...